| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 11/07/2002 | WO2002024927A3 Regulation of human adam-ts 1 precursor-like protein |
| 11/07/2002 | WO2002016561A3 Mfq-111, a novel human gtpase like protein |
| 11/07/2002 | WO2002012899A3 Peptides presented by cells |
| 11/07/2002 | WO2001095784A3 Diagnostic kit for invitro detection of hepatitis c |
| 11/07/2002 | WO2001092476A3 In vitro tissue test system |
| 11/07/2002 | WO2001092300A3 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 11/07/2002 | WO2001086002A9 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis |
| 11/07/2002 | WO2001077672A3 Molecularly imprinted polymer based sensors for the detection of narcotics |
| 11/07/2002 | WO2001071352A3 Compositions associated with complex formation |
| 11/07/2002 | WO2001053836A9 Identification, assessment, prevention, and therapy of prostate cancer |
| 11/07/2002 | WO2001048239A9 Screening method for nucleic acids |
| 11/07/2002 | WO2001045493A3 Transcription factor stress-related proteins and methods of use in plants |
| 11/07/2002 | WO2001042784A9 Methods for screening compounds active on neurons |
| 11/07/2002 | WO2001021220A9 Bioprosthetic heart valves |
| 11/07/2002 | WO2001020034A9 Methods and compositions for the screening of cell cycle modulators |
| 11/07/2002 | WO2001018045A9 Crystal structure of a deacetylase and inhibitors thereof |
| 11/07/2002 | WO2000031529A9 Devices and methods for performing blood coagulation assays by piezoelectric sensing |
| 11/07/2002 | US20020165674 Method and system for analyzing biological response signal data |
| 11/07/2002 | US20020165620 Adding plurality of substrates to plurality of aliquots of test sample, measuring reaction rates between protein and each substrate, determining activity or concentration of protein in test sample using predetermined sensitivity coefficient |
| 11/07/2002 | US20020165464 Assessment of organs for transplant, xenotransplant, and predicting time of death |
| 11/07/2002 | US20020165439 Method and apparatus for improving the accuracy of noninvasive hematocrit measurements |
| 11/07/2002 | US20020165381 Nucleic acid that codes for an androgen receptor, consists of a prefered nucleotide sequences or nucleotide sequence that corresponds to the sequence from first, or that hydbridizes with above first and second sequences |
| 11/07/2002 | US20020165380 A nucleic acid probe consisting a nucleic acid molecule of at least 15 nucleotides which is complementary to the antisense sequence of a unique fragment of the sequence of a nucleic acid molecule encoding a mammalian fb41 receptor |
| 11/07/2002 | US20020165379 An isolated nucleic acid encoding a monomer of a calcium-activated potassium channel, and the monomer having molecular weight 40-80 kDa, unit conductance 2-6-pS, binding to antibodies generated against specific peptide sequence |
| 11/07/2002 | US20020165378 Human membrane antigen tm4 superfamily protein and dna encoding this protein |
| 11/07/2002 | US20020165377 ADAM polynucleotides, polypeptides, and antibodies |
| 11/07/2002 | US20020165374 Secreted protein HFEAF41 |
| 11/07/2002 | US20020165373 Contacting the sample with an isolated recombinant immunodominant Neospora antigen, forming an antigen/antibody complex, and detecting the presence or absence of the complex |
| 11/07/2002 | US20020165364 Fluorescent indicator for use as tool in genetic engineerging |
| 11/07/2002 | US20020165361 Antibody for use in the diagnosis and treatment of cell proliferation disorders |
| 11/07/2002 | US20020165355 Methylated, SmD homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus |
| 11/07/2002 | US20020165353 Transport protein for use in human therapeutics and diagnostics |
| 11/07/2002 | US20020165352 Protein complex for use in the diagnosis and treatment of diabetes and nervous system disorders |
| 11/07/2002 | US20020165347 Polypeptide for use in the diagnosis, prevention and treatment of arteriosclerosis and vascular restenosis |
| 11/07/2002 | US20020165221 Cellular antigrowth agents |
| 11/07/2002 | US20020165188 Methods for inhibition of tumorigenic properties of melanoma cells |
| 11/07/2002 | US20020165186 Compounds that affect CD83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 11/07/2002 | US20020165167 Bacterial polypeptide deformylase (PDF) inhibitors, N-formyl hydroxylamine derivatives |
| 11/07/2002 | US20020165154 Lipoprotein-regulating medicaments |
| 11/07/2002 | US20020165150 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors |
| 11/07/2002 | US20020165143 Identification and isolation of novel DNA |
| 11/07/2002 | US20020165139 Construction of a structural variant of sublancin to facilitate its isolation and use in bioremediation of environmental contamination by gram-positive spore formers such as Bacillus anthrasis |
| 11/07/2002 | US20020165127 Antidiabetic agents |
| 11/07/2002 | US20020165116 Accurate measurement; ethylene oxide fatty alcohol adduct |
| 11/07/2002 | US20020164826 Apparatus for use in the detection of preferential particles in sample |
| 11/07/2002 | US20020164825 Matrix for detecting cancer cells in humans |
| 11/07/2002 | US20020164822 Biosensor |
| 11/07/2002 | US20020164818 Mass spectrometric immunoassay analysis of specific proteins and variants present in various biological fluids |
| 11/07/2002 | US20020164811 Novel method for measurement of glycated hemoglobin by a rapid strip test procedure |
| 11/07/2002 | US20020164810 Method and system for diagnosing pathology in biological samples by detection of infrared spectral markers |
| 11/07/2002 | US20020164809 Acid-labile isotope-coded extractant (ALICE) and its use in quantitative mass spectrometric analysis of protein mixtures |
| 11/07/2002 | US20020164806 Method and Apparatus for Rapid Fat Content Determination |
| 11/07/2002 | US20020164805 Method for checking the fitness for purpose of analysis elements |
| 11/07/2002 | US20020164793 Generating skin cells; obtain skin cells, keratinocytes and nutrient broths, culture cell, recover cells |
| 11/07/2002 | US20020164789 Suppressing glial cell activation in central nervous system; obtain mammal with brain disorder, administer modulator of nervous system activity, evaluate for adjusstment in brain disorder |
| 11/07/2002 | US20020164787 Immortal cell line derived from grouper Epinephelus coioides and its applications therein |
| 11/07/2002 | US20020164779 Immunoenzymatic analysis device for once-only use, and the relative analytical method |
| 11/07/2002 | US20020164767 DNA encoding the human serine protease C-E |
| 11/07/2002 | US20020164764 Transmembrane polypeptide expressed by lymphocytes |
| 11/07/2002 | US20020164734 Human pelota homolog |
| 11/07/2002 | US20020164717 Suppression of endothelial cell proliferation; obtain cells, incubate with modulators, monitor adjustment in cell proliferation |
| 11/07/2002 | US20020164715 Nucleotide seqences coding polypeptides for use in the treatment and diagnosis of cancer |
| 11/07/2002 | US20020164714 Nucleotie sequences coding polypeptide for use in the treatment of reproductive disorders |
| 11/07/2002 | US20020164707 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer, arthrits, pain, diabetes, migraine and inflammation, hypercalcemia, obesity, hypertension, and bone defects |
| 11/07/2002 | US20020164702 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders |
| 11/07/2002 | US20020164697 Nucleotide sequences coding polypeptides for use in treatment of autoimmune disease |
| 11/07/2002 | US20020164692 Immune system-related polynucleotides, polypeptides, and antibodies |
| 11/07/2002 | US20020164679 Polypeptides for use in the treatment of atherosclerosis and cardiovascular disorders |
| 11/07/2002 | US20020164676 Bacteriological examination system |
| 11/07/2002 | US20020164675 Methods of propagating and detecting infectious forms of intracellular pathogenic microorganisms |
| 11/07/2002 | US20020164674 Expression vector for use as diagnostic tool in genetic engineering |
| 11/07/2002 | US20020164673 Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same |
| 11/07/2002 | US20020164672 Detecting modulators of preferential enzyme activity; obtain sample containing enzymatic polypeptide, incubate with modulator, monitor adjustment in enzyme activity |
| 11/07/2002 | US20020164671 Compound for the detection of glucose in sample |
| 11/07/2002 | US20020164670 Lateral flow device utilising particulate carrier |
| 11/07/2002 | US20020164669 Secreted protein HRGDF73 |
| 11/07/2002 | US20020164668 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease |
| 11/07/2002 | US20020164663 Detecting cancer cell which are resistant to tamoxifen; obtain sample, incubate with preferential antibody, measure complex formation, compare to control, evaluate for tamoxifen resistance |
| 11/07/2002 | US20020164662 Myeloperoxidase, a risk indicator for cardiovascular disease |
| 11/07/2002 | US20020164661 Diagnostic method for a transmissible spongiform encephalopathy or a prion disease |
| 11/07/2002 | US20020164660 EGF-r detection kit and method |
| 11/07/2002 | US20020164659 Mixture for use in the detection of preferential particles in sample |
| 11/07/2002 | US20020164658 Methods and means of detecting nitric oxide synthase |
| 11/07/2002 | US20020164657 Detecting modulators of amyloid complex formation; obtain sample fluid containing aggregated amyloid peptide, incubate with modulator, monitor complex formation, adjustment in complex formation indicates modulator |
| 11/07/2002 | US20020164656 Microarrays and uses therefor |
| 11/07/2002 | US20020164655 Protein complex for use inthe diagnosis and treatment of nervous system disorders |
| 11/07/2002 | US20020164654 Diagnosing cell proliferative disorders; obtain tissue sample, incubae with binding agent, monitor binding, evaluate for cell proliferative disorders |
| 11/07/2002 | US20020164651 Diagnosing inflammatory defects associate with bone disorders; obtain fluid sample, measure the concentration of chlorinated peptide in sample, evaluate for arthritic bone disorder |
| 11/07/2002 | US20020164650 Methods of assessing wolframin protein activity |
| 11/07/2002 | US20020164649 Mass tags for quantitative analysis |
| 11/07/2002 | US20020164646 Nucleotide sequences coding polypeptide for use in the treatment and prevention of Inflammation, tumors, immunological, inflammatory bowel and crohn's disease |
| 11/07/2002 | US20020164645 Assays for taste receptor cell specific ion channel |
| 11/07/2002 | US20020164643 Surface impression composition for use in confining, isolating, detecting, analyzing and/or quantifying molecules in a sample |
| 11/07/2002 | US20020164642 Pool of immunoglobulin polypeptides for use in treating and preventing, inflammation, allergies, cancer, bacterial or viral infection, diabetes, arthritis, myasthenia gravis and autoimmune diseases |
| 11/07/2002 | US20020164641 Detecting modulators of tyrosine kinase activity; obtain expresion vector containg tyrosine kinase polypeptide, express vector, incubate with modulator, monitor adjustment activity or tyrosine kinase |
| 11/07/2002 | US20020164639 Process for determining antibiotics containing a b-lactam ring in biological fluid |
| 11/07/2002 | US20020164638 Kit for use in detection of enzyme inhibitors |
| 11/07/2002 | US20020164637 Detecting receptor binding ligands; obtain cell extract, incubate with modulator, detect binding, monitor activity from receptor |
| 11/07/2002 | US20020164636 High throughput assay for identification of gene expression modifiers |
| 11/07/2002 | US20020164633 Cell-based assay for detecting activation of poly (ADP-ribose) polymerase |